Immutep Limited announces a poster presentation on the TACTI-004 Phase III trial at the European Lung Cancer Congress 2025. Immutep Limited announced an upcoming poster presentation for its pivotal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results